Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

CSF biomarkers, including total-tau, neurofilament light chain (NfL) and amyloid-β, are increasingly being used to define and stage Alzheimer’s disease. These biomarkers can be measured more quickly and less invasively in plasma and may provide important information for early diagnosis of Alzheimer’...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Brain
Autori principali: de Wolf, Frank, Ghanbari, Mohsen, Licher, Silvan, McRae-McKee, Kevin, Gras, Luuk, Weverling, Gerrit Jan, Wermeling, Paulien, Sedaghat, Sanaz, Ikram, M Kamran, Waziry, Reem, Koudstaal, Wouter, Klap, Jaco, Kostense, Stefan, Hofman, Albert, Anderson, Roy, Goudsmit, Jaap, Ikram, M Arfan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7174054/
https://ncbi.nlm.nih.gov/pubmed/32206776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awaa054
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi